89bio (ETNB) News Today $8.88 -0.35 (-3.79%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$9.10 +0.22 (+2.49%) As of 03/3/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period What is Leerink Partnrs' Estimate for 89bio FY2029 Earnings?89bio, Inc. (NASDAQ:ETNB - Free Report) - Equities research analysts at Leerink Partnrs upped their FY2029 earnings per share (EPS) estimates for 89bio in a note issued to investors on Friday, February 28th. Leerink Partnrs analyst T. Smith now anticipates that the company will earn $3.71 per shaMarch 3 at 3:46 AM | marketbeat.comBank of America Securities Keeps Their Buy Rating on 89bio (ETNB)March 2 at 10:39 AM | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for 89bio (NASDAQ:ETNB)HC Wainwright reiterated a "buy" rating and set a $21.00 target price (down from $29.00) on shares of 89bio in a report on Friday.March 1 at 11:53 AM | marketbeat.com89bio (NASDAQ:ETNB) Announces Earnings Results, Misses Estimates By $0.42 EPS89bio (NASDAQ:ETNB - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($1.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by ($0.42).February 28, 2025 | marketbeat.com89bio price target lowered to $21 from $29 at H.C. WainwrightFebruary 28, 2025 | markets.businessinsider.com89bio reports Q4 EPS ($1.02), consensus (76c)February 27, 2025 | markets.businessinsider.com89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate UpdatesFebruary 27, 2025 | globenewswire.com89bio (ETNB) Projected to Post Earnings on Thursday89bio (NASDAQ:ETNB) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Shares Down 9.1% - What's Next?89bio (NASDAQ:ETNB) Shares Down 9.1% - Time to Sell?February 25, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Rating of "Moderate Buy" by AnalystsFebruary 25, 2025 | americanbankingnews.com89bio, Inc. (NASDAQ:ETNB) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating anFebruary 20, 2025 | marketbeat.comWeiss Ratings Reiterates Sell (D-) Rating for 89bio (NASDAQ:ETNB)Weiss Ratings reiterated a "sell (d-)" rating on shares of 89bio in a research note on Wednesday.February 20, 2025 | marketbeat.comabrdn plc Cuts Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)abrdn plc reduced its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 30.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 329,338 shares of the company's stock after selling 141,049 shares during the period. abrdn plc owned approxFebruary 10, 2025 | marketbeat.comInsider Buying Surges in February, Especially in These 6 StocksFebruary 9, 2025 | 247wallst.comInstitutional investors have a lot riding on 89bio, Inc. (NASDAQ:ETNB) with 58% ownershipFebruary 6, 2025 | uk.finance.yahoo.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)February 6, 2025 | globenewswire.com89bio (NASDAQ:ETNB) Stock Price Up 7.1% - Here's What Happened89bio (NASDAQ:ETNB) Stock Price Up 7.1% - What's Next?February 5, 2025 | marketbeat.comWolfe Research Initiates Coverage of 89bio (ETNB) with Outperform RecommendationFebruary 5, 2025 | msn.comFY2024 Earnings Estimate for 89bio Issued By Leerink Partnrs89bio, Inc. (NASDAQ:ETNB - Free Report) - Analysts at Leerink Partnrs boosted their FY2024 earnings estimates for 89bio in a report issued on Sunday, February 2nd. Leerink Partnrs analyst T. Smith now expects that the company will earn ($2.97) per share for the year, up from their prior forecastFebruary 5, 2025 | marketbeat.comWolfe Research Initiates Coverage on 89bio (NASDAQ:ETNB)Wolfe Research started coverage on 89bio in a report on Tuesday. They issued an "outperform" rating for the company.February 4, 2025 | marketbeat.comFY2029 Earnings Forecast for 89bio Issued By Leerink Partnrs89bio, Inc. (NASDAQ:ETNB - Free Report) - Leerink Partnrs issued their FY2029 earnings estimates for shares of 89bio in a research note issued on Sunday, February 2nd. Leerink Partnrs analyst T. Smith anticipates that the company will earn $3.68 per share for the year. The consensus estimate forFebruary 4, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Director Acquires $49,999,993.75 in StockFebruary 4, 2025 | insidertrades.com89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss RatingsWeiss Ratings reaffirmed a "sell (d-)" rating on shares of 89bio in a report on Saturday.February 4, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Short Interest Up 12.2% in January89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 7,790,000 shares, a growth of 12.2% from the December 31st total of 6,940,000 shares. Based on an average daily trading volume, of 943,200 shares, the short-interest ratio is presently 8.3 days.February 4, 2025 | marketbeat.comRa Capital Management, L.P. Acquires 5,714,285 Shares of 89bio, Inc. (NASDAQ:ETNB) Stock89bio, Inc. (NASDAQ:ETNB - Get Free Report) Director Ra Capital Management, L.P. acquired 5,714,285 shares of the stock in a transaction dated Thursday, January 30th. The shares were bought at an average price of $8.75 per share, with a total value of $49,999,993.75. Following the completion of the transaction, the director now directly owns 19,554,319 shares of the company's stock, valued at $171,100,291.25. The trade was a 41.29 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.February 3, 2025 | marketbeat.com89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesFebruary 3, 2025 | markets.businessinsider.comLeerink raises 89bio stock target to $37 on NASH study optimismFebruary 3, 2025 | msn.com89bio initiated with an Outperform at Wolfe ResearchFebruary 3, 2025 | markets.businessinsider.com89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’January 31, 2025 | markets.businessinsider.comUBS Group Boosts 89bio (NASDAQ:ETNB) Price Target to $38.00UBS Group upped their target price on 89bio from $25.00 to $38.00 and gave the company a "buy" rating in a report on Friday.January 31, 2025 | marketbeat.com89bio's SWOT analysis: pegozafermin's potential in MASH and SHTG marketsJanuary 30, 2025 | msn.com89bio (NASDAQ:ETNB) Stock Price Up 8.3% - Still a Buy?89bio (NASDAQ:ETNB) Trading 8.3% Higher - Here's WhyJanuary 30, 2025 | marketbeat.com89bio's Pegozafermin Is Now Gaining MomentumJanuary 30, 2025 | seekingalpha.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's Why89bio (NASDAQ:ETNB) Shares Gap Up - What's Next?January 29, 2025 | marketbeat.com89bio, Inc. Prices Upsized Public Offering of Common Stock and Pre-funded Warrants Expected to Raise Approximately $250 MillionJanuary 28, 2025 | quiverquant.com89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded WarrantsJanuary 28, 2025 | globenewswire.comWhy 89bio Stock Lagged the Market TodayJanuary 28, 2025 | fool.com89bio (NASDAQ:ETNB) Sees Unusually-High Trading Volume - Still a Buy?89bio (NASDAQ:ETNB) Sees Large Volume Increase - Still a Buy?January 28, 2025 | marketbeat.com89bio announces $250M common stock offeringJanuary 27, 2025 | markets.businessinsider.comBest, worst of biotech times: One company soars, another stumbles and a third seeks fundsJanuary 27, 2025 | bizjournals.com89bio seeks $250 million in public stock offeringJanuary 27, 2025 | msn.com89bio stock rallies 40% amid data for rival MASH drugJanuary 27, 2025 | msn.com89bio stock falls following public offering announcementJanuary 27, 2025 | msn.com89bio, Inc. Announces $250 Million Underwritten Public Offering of Common StockJanuary 27, 2025 | quiverquant.com89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded WarrantsJanuary 27, 2025 | globenewswire.com89bio (NASDAQ:ETNB) Shares Gap Up - Here's What Happened89bio (NASDAQ:ETNB) Shares Gap Up - Should You Buy?January 27, 2025 | marketbeat.comTraders Buy High Volume of Call Options on 89bio (NASDAQ:ETNB)89bio, Inc. (NASDAQ:ETNB - Get Free Report) was the recipient of some unusual options trading on Monday. Investors bought 2,228 call options on the company. This represents an increase of approximately 346% compared to the typical daily volume of 499 call options.January 27, 2025 | marketbeat.comJPMorgan Chase & Co. Has $736,000 Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)JPMorgan Chase & Co. boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 77.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 99,467 shares of the company's stock after purchasing an aJanuary 27, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from Analysts89bio, Inc. (NASDAQ:ETNB - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, four have issuedJanuary 26, 2025 | marketbeat.com89bio director McWherter buys $99,850 in stockJanuary 24, 2025 | msn.com Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.250.70▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼144▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA Biologics News Organon & Co. News Avidity Biosciences News Zai Lab News Scholar Rock News Arcellx News Alvotech News Biohaven News Rhythm Pharmaceuticals News Akero Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETNB Stock Alerts